Pluristem Therapeutics Inc.’s cell therapy products are designed to treat patients by stimulating their bodies’ own regenerative mechanisms

  • Clinical Programs

  • Products

  • Science & Technology

  • Benefits

    Technology platform for cell products, targeting treatment for a range of indications

  • Cell profiling expertise

    Deep understanding of the cell secretion profiles that generate therapeutic effects

  • Manufacturing facility

    Company-owned and operated GMP-certified manufacturing and research facilities


  • 22/11/2017Pluristem Granted Key U.S. Patent for Skeletal Muscle Regeneration – a Meaningful Asset Ahead of Upcoming Phase III Femoral Neck Fracture Study

    Read More